For instance, in the primary aldosteronism surgical outcome (PASO) study [10], 84.2% of patients who underwent surgery achieved clinical success (cure or significant improvement in blood pressure control), with a biochemical success rate of 93.9%, corresponding to “correction of hypokalemia and normalization of the aldosterone‐renin ratio (ARR).” This evidence concerns the gene REN and primary aldosteronism.